Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Potential Role of Donor CD3 Chimerism in Predicting Relapse after Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia (AML)

Maciej Kabat, Vanisha Patel, Sukhdeep Kaur, Michael Pelliccia, Charles Zhao, Patrick Roney, Alexandra Della Pia, Jaeil Ahn, David H. Vesole, Michele L. Donato, Hyung C Suh, Christina Cho, Pritish K. Bhattacharyya, Scott D Rowley, Andrew Ip

Blood (2024) 144 (Supplement 1): 7413.

https://doi.org/10.1182/blood-2024-204093

Published: 2024

Journal Articles

Survival Outcomes of US Patients Diagnosed with CMML over the Past Two Decades, Analysis from the SEER Database

Ayrton I Bangolo, Shraboni Dey, Rohan Mehta, Stacy H. Lee, Amer I Jarri, Simcha I Weissman, Christina Cho

Blood (2023) 142 (Supplement 1): 6485.

https://doi.org/10.1182/blood-2023-187919

Published: 2023

Journal Articles

Comparison of Non-Myeloablative Conditioning Regimens Flu/Bu2, Flu/Mel 100 and Flu/TBI in Patients with AML and MDS

Phyllis McKiernan, Simon Gelman, Scott D Rowley, Sukhdeep Kaur, Christina Cho, Hyung C Suh, Michele S Boonstra, Addi Georgantzis, Melissa Baker, Amy Einstein, Michele L. Donato

Blood (2023) 142 (Supplement 1): 6961.

https://doi.org/10.1182/blood-2023-187812

Published: 2023

Journal Articles

Comparison of Fludarabine/Cyclophosphamide Vs Bendamustine As Lymphodepleting Regimen for CAR-T: A Safety and Efficacy Analysis in Patients with Relapsed/ Refractory Multiple Myeloma

Sarvarinder Kaur Gill, Noa Biran, Pooja Phull, Sukhdeep Kaur, Hyung C Suh, Christina Cho, Michele L. Donato, Scott D Rowley, David H. Vesole, David S. Siegel, Harsh Parmar

Blood (2023) 142 (Supplement 1): 6903.

https://doi.org/10.1182/blood-2023-190507

Published: 2023

Journal Articles

Graft-Versus-Host Disease (GvHD) Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation (haplo-PBSCT) Using Abatacept in Combination with Post-Transplant Cyclophosphamide (PTCy)

Sukhdeep Kaur, Simon Gelman, Scott Rowley, Eliana Baker, Melissa Baker, Hyung C Suh, Christina Cho, Michele L. Donato

Blood (2023) 142 (Supplement 1): 6996.

https://doi.org/10.1182/blood-2023-184901

Published: 2023

Journal Articles

Dynamic Changes in Pre- and 3 Months Post-Transplant NGS MRD Status May Predict the Allogeneic Stem Cell Transplant Outcome of Patients with AML

Hyung C Suh, Amy Einstein, Addi Georgantzis, Phyllis McKiernan, Melissa Baker, Michele S Boonstra, Sukhdeep Kaur, Christina Cho, Scott D Rowley, Michele L. Donato

Blood (2023) 142 (Supplement 1): 2238.

https://doi.org/10.1182/blood-2023-185243

Published: 2023

Journal Articles

Fluoroquinolone-Resistant Enterobacteriaceae Prevalence for Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (aHSCT) in the Treatment of Multiple Myeloma (MM)

Elizabeth Titova, Scott Rowley, Barry Kreiswirth, Melissa Baker, Eliana Baker, Christina Cho, Anne S. Renteria, Alaa Ali, Pashna N. Munshi, Sukhdeep Kaur, Michele L. Donato, Chiranjeev Dash, Hyung C Suh, Kelly K. Yen, Austin J. Terlecky

Blood (2023) 142 (Supplement 1): 2223.

https://doi.org/10.1182/blood-2023-174405

Published: 2023

Journal Articles

Epidemiology and Independent Prognostic Factors of Patients with Hepatosplenic T-Cell Lymphoma over the Past 2 Decades

Ayrton I Bangolo, Shraboni Dey, Rohan Mehta, Amer I Jarri, Stacy H. Lee, Simcha I Weissman, Christina Cho

Blood (2023) 142 (Supplement 1): 6271.

https://doi.org/10.1182/blood-2023-185003

Published: 2023

Journal Articles

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Marcos J.G. de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, Michael T Hemmer, Mei-Jie Zhang, Fan Zhang, Richa Shah, Verna Welch, Saara Tikka, Erik Vandendries, Matthias Stelljes, David I. Marks, Wael Saber

Blood (2022) 140 (Supplement 1): 6023–6025.

https://doi.org/10.1182/blood-2022-160315

Published: 2022

Journal Articles

Association of Linguistic Barriers and Survival in Allogeneic Hematopoietic Cell Transplantation

Moneeza Walji, Jasme Lee, Sean M. Devlin, Francesca Gany, Miguel-Angel Perales, Sergio A Giralt, Christina Cho

Blood (2022) 140 (Supplement 1): 11018–11019.

https://doi.org/10.1182/blood-2022-169534

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Shlomo Elias, Moneeza Walji, Samantha Brown, Sean M. Devlin, Esperanza B. Papadopoulos, Ann A Jakubowski, Doris M Ponce, James W. Young, Sergio A Giralt, Miguel-Angel Perales, Brian C. Shaffer, Parastoo B. Dahi, Richard J. Lin, Christina Cho, Roni Tamari, Melody Smith, Boglarka Gyurkocza

Blood (2022) 140 (Supplement 1): 10627–10628.

https://doi.org/10.1182/blood-2022-170088

Published: 2022

Journal Articles

Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations

Blood (2022) 140 (Supplement 1): 4759–4761.

https://doi.org/10.1182/blood-2022-159303

Published: 2022

Journal Articles

Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Blood (2022) 140 (Supplement 1): 2137–2139.

https://doi.org/10.1182/blood-2022-157193

Published: 2022

Journal Articles

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Leland Metheny, Ronald M. Sobecks, Christina Cho, Jiasheng Wang, Lisa Ciarrone, Paolo F. Caimi, Folashade Otegbeye, Brenda W. Cooper, Molly Gallogly, Ehsan Malek, Aaron T. Gerds, Betty K. Hamilton, Sergio A Giralt, Miguel-Angel Perales, Marcos J.G. de Lima

Blood (2022) 140 (Supplement 1): 1887–1889.

https://doi.org/10.1182/blood-2022-169935

Published: 2022

Journal Articles

Analysis of 372 Adult Allograft Recipients Reveals Associations between Non-European Ancestry, Low Socioeconomic Status, and Receipt of HLA-Disparate Grafts

Warren Fingrut, Stephanie Chinapen, Angela Katrichis, Caroline Carino, Eric Davis, Brian C. Shaffer, Christina Cho, Gunjan L. Shah, Juliet N. Barker

Blood (2022) 140 (Supplement 1): 313–314.

https://doi.org/10.1182/blood-2022-168486

Published: 2022

Journal Articles

Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+ Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse

Brenda W. Cooper, Hyung C. Suh, Divya Koura, Guenther Koehne, Christina Cho, Nadia M. Bambace, Léa Bernard, Nirali N. Shah, Roland B. Walter, John F. DiPersio, Sritama Nath, Melissa M. Lee-Sundlov, Ali Lacy, Darren Stanizzi, Karen Kuhn, Jennifer S. Whangbo, Christopher Slapak, Glen D. Raffel

Blood (2022) 140 (Supplement 1): 12973–12975.

https://doi.org/10.1182/blood-2022-165289

Published: 2022

Journal Articles

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Blood (2022) 139 (24): 3546–3557.

https://doi.org/10.1182/blood.2021014520

Published: 2022

Includes: Supplemental data

Journal Articles

Post-Transplant Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia

Leland Metheny, III, Ronald M. Sobecks, Christina Cho, Paolo F. Caimi, Navneet S. Majhail, Folashade Otegbeye, Kirsten M Boughan, Brenda W. Cooper, Erin Galloway, Molly Gallogly, Ehsan Malek, Benjamin Tomlinson, Aaron T. Gerds, Betty K. Hamilton, Matt Kalaycio, Sergio A Giralt, Marcos J.G. de Lima

Blood (2021) 138 (Supplement 1): 2899.

https://doi.org/10.1182/blood-2021-153041

Published: 2021

Journal Articles

Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All"

Warren Fingrut, Ioannis Politikos, Eric Davis, Stephanie Chinapen, Kristine Naputo, Christina Cho, Sergio A Giralt, Boglarka Gyurkocza, Ann A Jakubowski, Esperanza B Papadopoulos, Miguel-Angel Perales, Doris M Ponce, Andromachi Scaradavou, Brian C Shaffer, Juliet N Barker

Blood (2021) 138 (Supplement 1): 423.

https://doi.org/10.1182/blood-2021-147329

Published: 2021

Journal Articles

MAIT and Vδ2 Unconventional T Cells Predict Favorable Outcome after Allogeneic HCT and Are Supported By a Diverse Intestinal Microbiome

Blood (2021) 138 (Supplement 1): 331.

https://doi.org/10.1182/blood-2021-151412

Published: 2021

NARROW

Potential Role of Donor CD3 Chimerism in Predicting Relapse after Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia (AML)

Survival Outcomes of US Patients Diagnosed with CMML over the Past Two Decades, Analysis from the SEER Database

Comparison of Non-Myeloablative Conditioning Regimens Flu/Bu2, Flu/Mel 100 and Flu/TBI in Patients with AML and MDS

Comparison of Fludarabine/Cyclophosphamide Vs Bendamustine As Lymphodepleting Regimen for CAR-T: A Safety and Efficacy Analysis in Patients with Relapsed/ Refractory Multiple Myeloma

Graft-Versus-Host Disease (GvHD) Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation (haplo-PBSCT) Using Abatacept in Combination with Post-Transplant Cyclophosphamide (PTCy)

Dynamic Changes in Pre- and 3 Months Post-Transplant NGS MRD Status May Predict the Allogeneic Stem Cell Transplant Outcome of Patients with AML

Fluoroquinolone-Resistant Enterobacteriaceae Prevalence for Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (aHSCT) in the Treatment of Multiple Myeloma (MM)

Epidemiology and Independent Prognostic Factors of Patients with Hepatosplenic T-Cell Lymphoma over the Past 2 Decades

Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study

Association of Linguistic Barriers and Survival in Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Leukemia

Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations

Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Analysis of 372 Adult Allograft Recipients Reveals Associations between Non-European Ancestry, Low Socioeconomic Status, and Receipt of HLA-Disparate Grafts

Trial in Progress: A First-in-Human Phase 1/2 Study of Hematopoietic Stem Cell Transplantation (HCT) with VOR33 (CD33-Deleted Allograft) Followed By Treatment with Gemtuzumab Ozogamicin (GO) in Patients with CD33+ Acute Myeloid Leukemia (AML) Who Are at High-Risk of Post-HCT Relapse

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Post-Transplant Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia

Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All"

MAIT and Vδ2 Unconventional T Cells Predict Favorable Outcome after Allogeneic HCT and Are Supported By a Diverse Intestinal Microbiome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only